Researchers at Washington University School of Medicine in St. Louis have been awarded $3.9 million in funding to continue…
Articles by Inês Martins, PhD
Adhering to a healthy diet — be it a Mediterranean diet, a prudent diet, or a diet…
Smokers and people with chronic obstructive pulmonary disease (COPD) are more likely to develop severe complications and die from…
People with chronic obstructive pulmonary disease (COPD) have three unusual stem cell subsets in their lungs that, together,…
MP1032, an anti-inflammatory molecule developed by MetrioPharm, inhibits the formation of 3-nitrotyrosine — a biomarker of nitrogen reactive…
People with chronic obstructive pulmonary disease (COPD) are among the most vulnerable to COVID-19 infections, being even more…
Patients with chronic obstructive pulmonary disease (COPD) who exhibit asthma symptoms may have poorer outcomes than other COPD patients, according to a study…
Treating older adults with chronic obstructive pulmonary disease (COPD) with opioids may not be the best idea. Researchers at St.
GlaxoSmithKline and Innoviva announced positive data from the Phase 3 FULFIL clinical trial evaluating their investigational triple combination therapy with fluticasone…